EpimedX, LLC is an Oklahoma-based biotechnology company that was founded in 2011 with the mission to develop Gene Regulation Therapy© – a promising technology that is expected to provide a safe, cost-effective, and permanent treatment for sickle cell disease, beta-thalassemia, and malaria without dangerous or harmful side effects.